The technique identifies individuals with a specific growth factor receptor common in those with non-small cell cancer.
The offending study, which claimed an algorithm could beat out human radiologists, is just one of many examples of this problematic pattern, the group wrote in Nature.
Doctors with Murayama Medical Center in Tokyo unveiled their device, which attaches to a normal pair of glasses, in the Journal of Neurosurgery: Spine.
Clinicians have long relied on x-ray and MRI to diagnose the condition, but both fall short in detecting subtle molecular changes.
German researchers reported success using Cerenkov luminescence imaging in 10 patients, according to a first-in-human study published in the Journal of Nuclear Medicine.
The ultrasound-guided approach may also be used in biopsy planning when MRI is not available, experts wrote in AJR.
As part of the endeavor, the Lou Ruvo Center for Brain Health will utilize advanced imaging techniques, such as diffusion-weighted MRI.
Imaging experts from two top institutions detailed five factors to consider prior to pulling the trigger.
Patients typically wait a while to understand if their treatment is working, but this imaging approach could reduce that time and help personalize care.
If providers can detect CHD before a child is born, doctors can begin life-saving care immediately after birth.
MIT’s AI lab, Philips, and Beth Israel Deaconess Medical Center are working to implement the system in the Boston institution’s emergency department this fall.
Previously, the algorithm was 90% accurate at predicting medical outcomes, but Georgia State University researchers believe they can do better.